Qiagen to acquire U.K. firm that makes genetic tests

09/22/2009 | Forbes

German firm Qiagen said it agreed to acquire DxS, a U.K.-based maker of genetic tests, in an effort to broaden its cancer diagnostics business. The deal entitles DxS to receive $95 million in cash from Qiagen and up to $35 million in additional payments if certain milestones are met.

View Full Article in:

Forbes

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Catheter Engineer Manager
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD